Area of research
Cardiology and Cardiovascular Medicine · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cardiac Valve Diseases and Treatments, Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management, and Pulmonary Hypertension Research and Treatments.
Left Atrial to Left Ventricular Volume Ratio in Patients With Severe Functional Mitral Regurgitation.
Quantification of perivascular adipose tissue attenuation does not add incremental prognostic value in patients undergoing transcatheter aortic valve implantation.
Annular remodelling predicts outcome in isolated severe tricuspid regurgitation: a registry-based echocardiographic analysis
Annular remodelling predicts outcome in isolated severe tricuspid regurgitation: a registry-based echocardiographic analysis.
Excess renin is attributed to the combination of forward and backward failure in HFrEF.
Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander?
Bleeding and thrombotic events in post-cardiotomy extracorporeal life support.
A streamlined, machine learning-derived approach to risk-stratification in heart failure patients with secondary tricuspid regurgitation.
Monitoring of mitral- and tricuspid valve interventions with CardioMEMS: Insights beyond imaging.
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction
Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry
Guideline directed medical therapy and reduction of secondary mitral regurgitation.
Reverse Remodeling Following Valve Replacement in Coexisting Aortic Stenosis and Transthyretin Cardiac Amyloidosis.
Fate of patients weaned from post-cardiotomy extracorporeal life support.
Hepatic T1-Time Predicts Cardiovascular Risk in All-Comers Referred for Cardiovascular Magnetic Resonance: A Post-Hoc Analysis.
Incidence, causes, correlates, and outcome of bioprosthetic valve dysfunction and failure following transcatheter aortic valve implantation
Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study.
Principal Morphomic and Functional Components of Secondary Mitral Regurgitation
Increased concentrations of bioactive adrenomedullin subsequently to angiotensin-receptor/neprilysin-inhibitor treatment in chronic systolic heart failure.
Fluid overload in patients undergoing TAVR: what we can learn from the nephrologists.
Secondary mitral regurgitation-Insights from microRNA assessment.
Impact of sex on the management and outcome of aortic stenosis patients: a female aortic valve stenosis paradox, and a call for personalized treatments?
Percutaneous bail-out in severe acute mitral regurgitation: when surgery is not an option.
Determinants of Bioprosthetic Aortic Valve Degeneration.
Global regurgitant volume: approaching the critical mass in valvular-driven heart failure.
N-terminal pro-brain natriuretic peptide and high-sensitivity troponin T exhibit additive prognostic value for the outcome of critically ill patients.
Natural History of Functional Tricuspid Regurgitation
Natural History of Functional Tricuspid Regurgitation: Implications of Quantitative Doppler Assessment.
A Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation.
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry.